Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchCamostatCamostat (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties

Hempel et al., Chemical Science, doi:10.1039/D1SC01494C
Dec 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In Vitro study showing that otamixaban inhibits SARS-CoV-2 cell entry through TMPRSS2 inhibition. Authors found otamixaban to be a weak TMPRSS2 inhibitor in cell culture (IC50 of 18.7 μM) compared to camostat (IC50 of 151.1 nM) and nafamostat (IC50 of 11.8 nM). However, in precision cut human lung slices (PCLS), otamixaban was as potent as camostat in inhibiting SARS-CoV-2 infection. Most notably, otamixaban showed strong synergistic effects when combined with sub-nanomolar concentrations of camostat or nafamostat in Calu-3 lung cells, reducing the required dose of otamixaban by approximately 25-fold. Molecular dynamics simulations revealed that otamixaban binds to the S1 pocket of TMPRSS2 with multiple metastable binding modes, sharing binding sites with camostat and nafamostat. Authors suggest otamixaban combined with camostat or nafamostat as a promising COVID-19 therapeutic strategy.
3 preclinical studies support the efficacy of camostat for COVID-19:
Hempel et al., 31 Dec 2021, Germany, peer-reviewed, 13 authors. Contact: frank.noe@fu-berlin.de.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperCamostatAll
Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties
Tim Hempel, Katarina Elez, Nadine Krüger, Lluís Raich, Jonathan H Shrimp, Olga Danov, Danny Jonigk, Armin Braun, Min Shen, Matthew D Hall, Stefan Pöhlmann, Markus Hoffmann, Frank Noé
Chemical Science, doi:10.1039/d1sc01494c
SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host cell proteins for viral entry into human lung cells. One of them, the protease TMPRSS2, is required to activate the viral spike protein (S). Even though two inhibitors, camostat and nafamostat, are known to inhibit TMPRSS2 and block cell entry of SARS-CoV-2, finding further potent therapeutic options is still an important task. In this study, we report that a late-stage drug candidate, otamixaban, inhibits SARS-CoV-2 cell entry. We show that otamixaban suppresses TMPRSS2 activity and SARS-CoV-2 infection of a human lung cell line, although with lower potency than camostat or nafamostat. In contrast, otamixaban inhibits SARS-CoV-2 infection of precision cut lung slices with the same potency as camostat. Furthermore, we report that otamixaban's potency can be significantly enhanced by (sub-) nanomolar nafamostat or camostat supplementation. Dominant molecular TMPRSS2-otamixaban interactions are assessed by extensive 109 ms of atomistic molecular dynamics simulations. Our findings suggest that combinations of otamixaban with supplemental camostat or nafamostat are a promising option for the treatment of COVID-19.
Author contributions
References
Abou-Ismail, Diamond, Kapoor, Arafah, Nayak, The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management, Thromb. Res
Azouz, Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2, Pathog. Immun
Berger Rentsch, Zimmer, A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon, PLoS One
Bertram, Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease, J. Virol
Bertram, TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium, J. Virol
Bestle, TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells, Life Sci. Alliance
Brinkmann, The Glycoprotein of Vesicular Stomatitis Virus Promotes Release of Virus-like Particles from Tetherin-Positive Cells, PLoS One
Böttcher, Proteolytic Activation of Inuenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium, J. Virol
Chaipan, Proteolytic Activation of the 1918 Inuenza Virus Hemagglutinin, J. Virol
Chou, Talalay, Quantitative analysis of doseeffect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul
Chou, Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies, Pharmacol. Rev
Chu, Pharmacological Characterization of a Novel Factor Xa Inhibitor, FXV673, Thromb. Res
Eastman, OpenMM 7: Rapid Development of High Performance Algorithms for Molecular Dynamics, PLoS Comput. Biol
Elez, Krüger, Shen, Hall, Pöhlmann et al., Frank Noé proposed drug combination experiments and analyzed drug combination data
Gierer, The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies, J. Virol
Glowacka, Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response, J. Virol
Guertin, Choi, The Discovery of the Factor Xa Inhibitor Otamixaban: From Lead Identication to Clinical Development, Curr. Med. Chem
Guertin, Optimization of the _-Aminoester class of factor Xa inhibitors. part 2: Identication of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity, Bioorg. Med. Chem. Lett
Hedstrom, Serine Protease Mechanism and Specicity, Chem. Rev
Hempel, Molecular mechanism of inhibiting the SARS-CoV-2 cell entry facilitator TMPRSS2 with camostat and nafamostat, Chem. Sci
Hoffmann, Camostat Mesylate Inhibits SARS-CoV-2 Activation by TMPRSS2-Related Proteases and Its Metabolite GBPA Exerts Antiviral Activity, EBioMedicine
Hoffmann, Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2, Nature
Hoffmann, Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19, Antimicrob. Agents Chemother
Hoffmann, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell
Hopkins, Le Grand, Walker, Roitberg, Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning, J. Chem. Theory Comput
Hu, Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19, ACS Pharmacol. Transl. Sci
Hu, Guo, Zhou, Shi, Characteristics of SARS-CoV-2 and COVID-19, Nat. Rev. Microbiol
Humphrey, Dalke, Schulten, VMD: Visual Molecular Dynamics, J. Mol. Graph
Jorgensen, Chandrasekhar, Madura, Impey, Klein, Comparison of Simple Potential Functions for Simulating Liquid Water, J. Chem. Phys
Kastenhuber, Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry, bioRxiv, doi:10.1101/2021.03.31.437960
Kim, Heinlein, Hackman, Nelson, Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease, Mol. Cell. Biol
Kleine-Weber, Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization, J. Virol
Koes, Baumgartner, Camacho, Lessons Learned in Empirical Scoring with smina from the CSAR 2011 Benchmarking Exercise, J. Chem. Inf. Model
Maier, ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB, J. Chem. Theory Comput
Matsuyama, Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2, J. Virol
Montopoli, Androgen-Deprivation Therapies for Prostate Cancer and Risk of Infection by SARS-CoV-2: A Population-Based Study (N ¼ 4532), Ann. Oncol
Morris, AutoDock4 and AutoDockTools4: Automated docking with selective receptor exibility, J. Comput. Chem
Neuhaus, Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-Cut Lung Slices, J. Visualized Exp
Noé, Wu, Prinz, Plattner, Projected and Hidden Markov Models for Calculating Kinetics and Metastable States of Complex Molecules, J. Chem. Phys
Ou, Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2, PLoS Pathog
Paccaly, Pharmacodynamic markers in the early clinical assessment of otamixaban, a direct factor Xa inhibitor, Thromb. Haemostasis
Paccaly, Pharmacokinetics of Otamixaban, a Direct Factor Xa Inhibitor, in Healthy Male Subjects: Pharmacokinetic Model Development for Phase 2/3 Simulation of Exposure, J. Clin. Pharmacol
Qiu, Development and Benchmarking of Open Force Field v1.0.0, the Parsley Small Molecule Force Field, doi:10.33774/chemrxiv-2021-l070l-v3
Quiroga, Villarreal, Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening, PloS One
Rabiner, A Tutorial on Hidden Markov Models and Selected Applications in Speech Recognition
Rao, Spichty, Thermodynamics and Kinetics of Large-Time-Step Molecular Dynamics, J. Comput. Chem
Rensi, Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells, ChemRxiv, doi:10.26434/chemrxiv.12009582
Sakai, The Host Protease TMPRSS2 Plays a Major Role in in Vivo Replication of Emerging H7N9 and Seasonal Inuenza Viruses, J. Virol
Scherer, PyEMMA 2: A Soware Package for Estimation, Validation, and Analysis of Markov Models, J. Chem. Theory Comput
Schuler, Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium, J. Clin. Invest
Shirato, Kawase, Matsuyama, Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2, J. Virol
Shrimp, An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19, ACS Pharmacol. Transl. Sci
Shulla, A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry, J. Virol
Steg, Anticoagulation With Otamixaban and Ischemic in Non-ST-Segment Elevation Acute Coronary Syndromes, JAMA, J. Am. Med. Assoc
Sterling, Irwin, ZINC 15 -Ligand Discovery for Everyone, J. Chem. Inf. Model
Sun, Sanderson, Zheng, Drug combination therapy increases successful drug repositioning, Drug Discovery Today
Trott, Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem
Virtanen, SciPy 1.0: Fundamental Algorithms for Scientic Computing in Python, Nat. Methods
Wu, Noé, Variational Approach for Learning Markov Processes from Time Series Data, J. Nonlinear Sci
DOI record: { "DOI": "10.1039/d1sc01494c", "ISSN": [ "2041-6520", "2041-6539" ], "URL": "http://dx.doi.org/10.1039/D1SC01494C", "abstract": "<jats:p>SARS-CoV-2, the cause of the COVID-19 pandemic, exploits host proteins for viral entry into human lung cells and is blocked by otamixaban in combination with a covalent protease inhibitor.</jats:p>", "author": [ { "ORCID": "https://orcid.org/0000-0002-0073-9353", "affiliation": [ { "name": "Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany" }, { "name": "Department of Physics, Freie Universität Berlin, Berlin, Germany" } ], "authenticated-orcid": false, "family": "Hempel", "given": "Tim", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0002-6160-8701", "affiliation": [ { "name": "Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany" } ], "authenticated-orcid": false, "family": "Elez", "given": "Katarina", "sequence": "additional" }, { "affiliation": [ { "name": "Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany" } ], "family": "Krüger", "given": "Nadine", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-5493-6205", "affiliation": [ { "name": "Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany" } ], "authenticated-orcid": false, "family": "Raich", "given": "Lluís", "sequence": "additional" }, { "affiliation": [ { "name": "National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA" } ], "family": "Shrimp", "given": "Jonathan H.", "sequence": "additional" }, { "affiliation": [ { "name": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Hannover, Germany" } ], "family": "Danov", "given": "Olga", "sequence": "additional" }, { "affiliation": [ { "name": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Hannover, Germany" }, { "name": "Institute of Pathology, Hannover Medical School, Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Hannover, Germany" } ], "family": "Jonigk", "given": "Danny", "sequence": "additional" }, { "affiliation": [ { "name": "Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Member of Fraunhofer International Consortium for Anti-Infective Research (iCAIR), Hannover, Germany" } ], "family": "Braun", "given": "Armin", "sequence": "additional" }, { "affiliation": [ { "name": "National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA" } ], "family": "Shen", "given": "Min", "sequence": "additional" }, { "affiliation": [ { "name": "National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA" } ], "family": "Hall", "given": "Matthew D.", "sequence": "additional" }, { "affiliation": [ { "name": "Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany" }, { "name": "Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany" } ], "family": "Pöhlmann", "given": "Stefan", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4603-7696", "affiliation": [ { "name": "Infection Biology Unit, German Primate Center – Leibniz Institute for Primate Research, Göttingen, Germany" }, { "name": "Faculty of Biology and Psychology, University Göttingen, Göttingen, Germany" } ], "authenticated-orcid": false, "family": "Hoffmann", "given": "Markus", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4169-9324", "affiliation": [ { "name": "Department of Mathematics and Computer Science, Freie Universität Berlin, Berlin, Germany" }, { "name": "Department of Physics, Freie Universität Berlin, Berlin, Germany" }, { "name": "Department of Chemistry, Rice University, Houston, TX, USA" } ], "authenticated-orcid": false, "family": "Noé", "given": "Frank", "sequence": "additional" } ], "container-title": "Chemical Science", "container-title-short": "Chem. Sci.", "content-domain": { "crossmark-restriction": true, "domain": [ "rsc.org" ] }, "created": { "date-parts": [ [ 2021, 8, 26 ] ], "date-time": "2021-08-26T13:21:31Z", "timestamp": 1629984091000 }, "deposited": { "date-parts": [ [ 2024, 4, 18 ] ], "date-time": "2024-04-18T02:46:25Z", "timestamp": 1713408385000 }, "funder": [ { "DOI": "10.13039/501100000780", "award": [ "ERC CoG 772230 “ScaleCell”", "ERC Consolidator Grant 771883 “XHale”" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100000780", "id-type": "DOI" } ], "name": "European Commission" }, { "DOI": "10.13039/501100019239", "award": [ "AA1-6", "AA1-10" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100019239", "id-type": "DOI" } ], "name": "Berlin Mathematics Research Center MATH+" }, { "DOI": "10.13039/501100001659", "award": [ "PO 716/11-1", "PO 716/14-1", "SFB 1114, Project C03", "SFB/TRR 186, Project A12" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100001659", "id-type": "DOI" } ], "name": "Deutsche Forschungsgemeinschaft" }, { "DOI": "10.13039/501100002347", "award": [ "ANI-CoV 01KI2074A", "BIFOLD", "COVIM 01KX2021", "RAPID 01KI1723D, 01KI2006D", "RENACO 01KI20328A", "SARS_S1S2 01KI20396" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100002347", "id-type": "DOI" } ], "name": "Bundesministerium für Bildung und Forschung" }, { "DOI": "10.13039/100010665", "award": [ "897414" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100010665", "id-type": "DOI" } ], "name": "H2020 Marie Skłodowska-Curie Actions" }, { "DOI": "10.13039/100006108", "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100006108", "id-type": "DOI" } ], "name": "National Center for Advancing Translational Sciences" }, { "DOI": "10.13039/501100003185", "award": [ "Anti-Corona 840260 DRECOR" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/501100003185", "id-type": "DOI" } ], "name": "Fraunhofer-Gesellschaft" } ], "indexed": { "date-parts": [ [ 2025, 2, 21 ] ], "date-time": "2025-02-21T17:25:44Z", "timestamp": 1740158744671, "version": "3.37.3" }, "is-referenced-by-count": 15, "issue": "38", "issued": { "date-parts": [ [ 2021 ] ] }, "journal-issue": { "issue": "38", "published-print": { "date-parts": [ [ 2021, 10, 6 ] ] } }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by-nc/3.0/", "content-version": "vor", "delay-in-days": 237, "start": { "date-parts": [ [ 2021, 8, 26 ] ], "date-time": "2021-08-26T00:00:00Z", "timestamp": 1629936000000 } } ], "link": [ { "URL": "http://pubs.rsc.org/en/content/articlepdf/2021/SC/D1SC01494C", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "292", "original-title": [], "page": "12600-12609", "prefix": "10.1039", "published": { "date-parts": [ [ 2021 ] ] }, "published-online": { "date-parts": [ [ 2021 ] ] }, "publisher": "Royal Society of Chemistry (RSC)", "reference": [ { "DOI": "10.1038/s41579-020-00459-7", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "141", "journal-title": "Nat. Rev. Microbiol.", "key": "D1SC01494C/cit1", "volume": "19", "year": "2020" }, { "author": "The World Health Organization", "key": "D1SC01494C/cit2", "unstructured": "The World Health Organization , Weekly Epidemiological Update, Coronavirus disease 2019 (COVID-19) , 9 March 2021", "volume-title": "Weekly Epidemiological Update, Coronavirus disease 2019 (COVID-19)", "year": "9 March 2021" }, { "DOI": "10.1039/D0SC05064D", "author": "Hempel", "doi-asserted-by": "crossref", "first-page": "983", "journal-title": "Chem. Sci.", "key": "D1SC01494C/cit3", "volume": "12", "year": "2021" }, { "DOI": "10.1016/j.cell.2020.02.052", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "issue": "2", "journal-title": "Cell", "key": "D1SC01494C/cit4", "volume": "181", "year": "2020" }, { "DOI": "10.1172/JCI140766", "author": "Schuler", "doi-asserted-by": "crossref", "first-page": "e140766", "issue": "1", "journal-title": "J. Clin. Invest.", "key": "D1SC01494C/cit5", "volume": "131", "year": "2021" }, { "author": "Montopoli", "journal-title": "Ann. Oncol.", "key": "D1SC01494C/cit6", "year": "2020" }, { "DOI": "10.1038/s41586-020-2575-3", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "588", "issue": "7826", "journal-title": "Nature", "key": "D1SC01494C/cit7", "volume": "585", "year": "2020" }, { "DOI": "10.1371/journal.ppat.1009212", "author": "Ou", "doi-asserted-by": "crossref", "first-page": "e1009212", "issue": "1", "journal-title": "PLoS Pathog.", "key": "D1SC01494C/cit8", "volume": "17", "year": "2021" }, { "DOI": "10.1101/2021.03.31.437960", "author": "Kastenhuber", "doi-asserted-by": "publisher", "journal-title": "bioRxiv.", "key": "D1SC01494C/cit9", "year": "2021" }, { "DOI": "10.1128/JVI.01542-10", "author": "Matsuyama", "doi-asserted-by": "crossref", "first-page": "12658", "issue": "24", "journal-title": "J. Virol.", "key": "D1SC01494C/cit10", "volume": "84", "year": "2010" }, { "DOI": "10.1128/JVI.02062-10", "author": "Shulla", "doi-asserted-by": "crossref", "first-page": "873", "issue": "2", "journal-title": "J. Virol.", "key": "D1SC01494C/cit11", "volume": "85", "year": "2010" }, { "DOI": "10.1128/JVI.02232-10", "author": "Glowacka", "doi-asserted-by": "crossref", "first-page": "4122", "issue": "9", "journal-title": "J. Virol.", "key": "D1SC01494C/cit12", "volume": "85", "year": "2011" }, { "DOI": "10.1128/JVI.05300-11", "author": "Bertram", "doi-asserted-by": "crossref", "first-page": "13363", "issue": "24", "journal-title": "J. Virol.", "key": "D1SC01494C/cit13", "volume": "85", "year": "2011" }, { "DOI": "10.1128/JVI.00128-13", "author": "Gierer", "doi-asserted-by": "crossref", "first-page": "5502", "issue": "10", "journal-title": "J. Virol.", "key": "D1SC01494C/cit14", "volume": "87", "year": "2013" }, { "DOI": "10.1128/JVI.03372-12", "author": "Bertram", "doi-asserted-by": "crossref", "first-page": "6150", "issue": "11", "journal-title": "J. Virol.", "key": "D1SC01494C/cit15", "volume": "87", "year": "2013" }, { "DOI": "10.1128/JVI.01890-13", "author": "Shirato", "doi-asserted-by": "crossref", "first-page": "12552", "issue": "23", "journal-title": "J. Virol.", "key": "D1SC01494C/cit16", "volume": "87", "year": "2013" }, { "DOI": "10.1128/JVI.01118-06", "author": "Böttcher", "doi-asserted-by": "crossref", "first-page": "9896", "issue": "19", "journal-title": "J. Virol.", "key": "D1SC01494C/cit17", "volume": "80", "year": "2006" }, { "DOI": "10.1128/JVI.02205-08", "author": "Chaipan", "doi-asserted-by": "crossref", "first-page": "3200", "issue": "7", "journal-title": "J. Virol.", "key": "D1SC01494C/cit18", "volume": "83", "year": "2009" }, { "DOI": "10.1128/JVI.03677-13", "author": "Sakai", "doi-asserted-by": "crossref", "first-page": "5608", "issue": "10", "journal-title": "J. Virol.", "key": "D1SC01494C/cit19", "volume": "88", "year": "2014" }, { "DOI": "10.1128/MCB.26.3.965-975.2006", "author": "Kim", "doi-asserted-by": "crossref", "first-page": "965", "issue": "3", "journal-title": "Mol. Cell. Biol.", "key": "D1SC01494C/cit20", "volume": "26", "year": "2006" }, { "DOI": "10.1016/j.ebiom.2021.103255", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "103255", "journal-title": "EBioMedicine", "key": "D1SC01494C/cit21", "volume": "65", "year": "2021" }, { "DOI": "10.1128/AAC.00754-20", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "e00754", "issue": "6", "journal-title": "Antimicrob. Agents Chemother.", "key": "D1SC01494C/cit22", "volume": "64", "year": "2020" }, { "DOI": "10.20411/pai.v6i1.408", "author": "Azouz", "doi-asserted-by": "crossref", "first-page": "55", "issue": "1", "journal-title": "Pathog. Immun.", "key": "D1SC01494C/cit23", "volume": "6", "year": "2021" }, { "DOI": "10.26508/lsa.202000786", "author": "Bestle", "doi-asserted-by": "crossref", "first-page": "e202000786", "issue": "9", "journal-title": "Life Sci. Alliance", "key": "D1SC01494C/cit24", "volume": "3", "year": "2020" }, { "DOI": "10.1016/S0960-894X(02)00213-5", "author": "Guertin", "doi-asserted-by": "crossref", "first-page": "1671", "issue": "12", "journal-title": "Bioorg. Med. Chem. Lett", "key": "D1SC01494C/cit25", "volume": "12", "year": "2002" }, { "DOI": "10.1001/jama.2013.277165", "author": "Steg", "doi-asserted-by": "crossref", "first-page": "1145", "issue": "11", "journal-title": "JAMA, J. Am. Med. Assoc.", "key": "D1SC01494C/cit26", "volume": "310", "year": "2013" }, { "DOI": "10.26434/chemrxiv.12009582", "author": "Rensi", "doi-asserted-by": "publisher", "journal-title": "ChemRxiv", "key": "D1SC01494C/cit27", "year": "2020" }, { "DOI": "10.1021/acsptsci.0c00221", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "1124", "issue": "3", "journal-title": "ACS Pharmacol. Transl. Sci.", "key": "D1SC01494C/cit28", "volume": "4", "year": "2021" }, { "DOI": "10.1021/acsptsci.0c00106", "author": "Shrimp", "doi-asserted-by": "crossref", "first-page": "997", "issue": "5", "journal-title": "ACS Pharmacol. Transl. Sci.", "key": "D1SC01494C/cit29", "volume": "3", "year": "2020" }, { "DOI": "10.1016/j.drudis.2016.05.015", "author": "Sun", "doi-asserted-by": "crossref", "first-page": "1189", "issue": "7", "journal-title": "Drug Discovery Today", "key": "D1SC01494C/cit30", "volume": "21", "year": "2016" }, { "DOI": "10.1016/0065-2571(84)90007-4", "author": "Chou", "doi-asserted-by": "crossref", "first-page": "27", "journal-title": "Adv. Enzyme Regul.", "key": "D1SC01494C/cit31", "volume": "22", "year": "1984" }, { "DOI": "10.1124/pr.58.3.10", "author": "Chou", "doi-asserted-by": "crossref", "first-page": "621", "issue": "3", "journal-title": "Pharmacol. Rev.", "key": "D1SC01494C/cit32", "volume": "58", "year": "2006" }, { "DOI": "10.1016/S0049-3848(01)00328-0", "author": "Chu", "doi-asserted-by": "crossref", "first-page": "309", "issue": "4", "journal-title": "Thromb. Res.", "key": "D1SC01494C/cit33", "volume": "103", "year": "2001" }, { "DOI": "10.2174/092986707782023659", "author": "Guertin", "doi-asserted-by": "crossref", "first-page": "2471", "issue": "23", "journal-title": "Curr. Med. Chem.", "key": "D1SC01494C/cit34", "volume": "14", "year": "2007" }, { "DOI": "10.1177/0091270005281817", "author": "Paccaly", "doi-asserted-by": "crossref", "first-page": "37", "issue": "1", "journal-title": "J. Clin. Pharmacol.", "key": "D1SC01494C/cit35", "volume": "46", "year": "2006" }, { "DOI": "10.1021/cr000033x", "author": "Hedstrom", "doi-asserted-by": "crossref", "first-page": "4501", "issue": "12", "journal-title": "Chem. Rev.", "key": "D1SC01494C/cit36", "volume": "102", "year": "2002" }, { "DOI": "10.1016/j.thromres.2020.06.029", "author": "Abou-Ismail", "doi-asserted-by": "crossref", "first-page": "101", "journal-title": "Thromb. Res.", "key": "D1SC01494C/cit37", "volume": "194", "year": "2020" }, { "DOI": "10.1160/TH05-05-0347", "author": "Paccaly", "doi-asserted-by": "crossref", "first-page": "1156", "issue": "12", "journal-title": "Thromb. Haemostasis", "key": "D1SC01494C/cit38", "volume": "94", "year": "2005" }, { "DOI": "10.1371/journal.pone.0189073", "author": "Brinkmann", "doi-asserted-by": "crossref", "first-page": "e0189073", "issue": "12", "journal-title": "PLoS One", "key": "D1SC01494C/cit39", "volume": "12", "year": "2017" }, { "DOI": "10.1128/JVI.01381-18", "author": "Kleine-Weber", "doi-asserted-by": "crossref", "issue": "2", "journal-title": "J. Virol.", "key": "D1SC01494C/cit40", "volume": "93", "year": "2019" }, { "DOI": "10.1371/journal.pone.0025858", "author": "Berger Rentsch", "doi-asserted-by": "crossref", "first-page": "e25858", "issue": "10", "journal-title": "PLoS One", "key": "D1SC01494C/cit41", "volume": "6", "year": "2011" }, { "author": "Neuhaus", "first-page": "e57042", "journal-title": "J. Visualized Exp.", "key": "D1SC01494C/cit42", "volume": "135", "year": "2018" }, { "DOI": "10.1021/acs.jcim.5b00559", "author": "Sterling", "doi-asserted-by": "crossref", "first-page": "2324", "issue": "11", "journal-title": "J. Chem. Inf. Model.", "key": "D1SC01494C/cit43", "volume": "55", "year": "2015" }, { "DOI": "10.1002/jcc.21256", "author": "Morris", "doi-asserted-by": "crossref", "first-page": "2785", "issue": "16", "journal-title": "J. Comput. Chem.", "key": "D1SC01494C/cit44", "volume": "30", "year": "2009" }, { "DOI": "10.1021/ci300604z", "author": "Koes", "doi-asserted-by": "crossref", "first-page": "1893", "issue": "8", "journal-title": "J. Chem. Inf. Model.", "key": "D1SC01494C/cit45", "volume": "53", "year": "2013" }, { "DOI": "10.1002/jcc.21334", "author": "Trott", "doi-asserted-by": "crossref", "first-page": "455", "issue": "2", "journal-title": "J. Comput. Chem.", "key": "D1SC01494C/cit46", "volume": "31", "year": "2010" }, { "DOI": "10.1371/journal.pone.0155183", "author": "Quiroga", "doi-asserted-by": "crossref", "first-page": "e0155183", "issue": "5", "journal-title": "PloS One", "key": "D1SC01494C/cit47", "volume": "11", "year": "2016" }, { "DOI": "10.1371/journal.pcbi.1005659", "author": "Eastman", "doi-asserted-by": "crossref", "first-page": "e1005659", "issue": "7", "journal-title": "PLoS Comput. Biol.", "key": "D1SC01494C/cit48", "volume": "13", "year": "2017" }, { "DOI": "10.1021/acs.jctc.5b00255", "author": "Maier", "doi-asserted-by": "crossref", "first-page": "3696", "issue": "8", "journal-title": "J. Chem. Theory Comput.", "key": "D1SC01494C/cit49", "volume": "11", "year": "2015" }, { "DOI": "10.33774/chemrxiv-2021-l070l-v3", "author": "Qiu", "doi-asserted-by": "publisher", "journal-title": "ChemRxiv", "key": "D1SC01494C/cit50", "year": "2021" }, { "DOI": "10.1063/1.445869", "author": "Jorgensen", "doi-asserted-by": "crossref", "first-page": "926", "issue": "2", "journal-title": "J. Chem. Phys.", "key": "D1SC01494C/cit51", "volume": "79", "year": "1983" }, { "DOI": "10.1021/ct5010406", "author": "Hopkins", "doi-asserted-by": "crossref", "first-page": "1864", "issue": "4", "journal-title": "J. Chem. Theory Comput.", "key": "D1SC01494C/cit52", "volume": "11", "year": "2015" }, { "DOI": "10.1002/jcc.21990", "author": "Rao", "doi-asserted-by": "crossref", "first-page": "475", "issue": "5", "journal-title": "J. Comput. Chem.", "key": "D1SC01494C/cit53", "volume": "33", "year": "2012" }, { "DOI": "10.1016/0263-7855(96)00018-5", "author": "Humphrey", "doi-asserted-by": "crossref", "first-page": "33", "issue": "1", "journal-title": "J. Mol. Graph.", "key": "D1SC01494C/cit54", "volume": "14", "year": "1996" }, { "DOI": "10.1021/acs.jctc.5b00743", "author": "Scherer", "doi-asserted-by": "crossref", "first-page": "5525", "issue": "11", "journal-title": "J. Chem. Theory Comput.", "key": "D1SC01494C/cit55", "volume": "11", "year": "2015" }, { "DOI": "10.1007/s00332-019-09567-y", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "23", "issue": "1", "journal-title": "J. Nonlinear Sci.", "key": "D1SC01494C/cit56", "volume": "30", "year": "2019" }, { "DOI": "10.1063/1.4828816", "author": "Noé", "doi-asserted-by": "crossref", "first-page": "184114", "issue": "18", "journal-title": "J. Chem. Phys.", "key": "D1SC01494C/cit57", "volume": "139", "year": "2013" }, { "DOI": "10.1109/5.18626", "author": "Rabiner", "doi-asserted-by": "crossref", "first-page": "257", "issue": "2", "journal-title": "Proc. IEEE", "key": "D1SC01494C/cit58", "volume": "77", "year": "1989" }, { "DOI": "10.1038/s41592-019-0686-2", "author": "Virtanen", "doi-asserted-by": "crossref", "first-page": "261", "journal-title": "Nat. Methods", "key": "D1SC01494C/cit59", "volume": "17", "year": "2020" } ], "reference-count": 59, "references-count": 59, "relation": {}, "resource": { "primary": { "URL": "https://xlink.rsc.org/?DOI=D1SC01494C" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Synergistic inhibition of SARS-CoV-2 cell entry by otamixaban and covalent protease inhibitors: pre-clinical assessment of pharmacological and molecular properties", "type": "journal-article", "update-policy": "https://doi.org/10.1039/rsc_crossmark_policy", "volume": "12" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit